Cryotherapy involves the use of low temperature cryogenic gases for the treatment of various disease conditions in oncology, cardiology, dermatology, and pain management. It is mainly used in the treatment of varied cancer types including prostate, skin, and cervical cancer; benign tumors; and in pain management.
There are various types of devices available in the cryotherapy market for cryosurgery, icepack therapy, and chamber therapy. Sprays, dipsticks, cryo probes, and forcep techniques are some of the major technologies employed in this treatment method.
Cryotherapy provides several advantages over other treatments and conventional procedures. Following are few of the merits of cryotherapy:
On the other hand, cryotherapy has several adverse effects, such as nerve irritation, numbness or tingling of tissue, redness, and irritation of the skin.
As the cryotherapy market is growing steadily, several companies have begun focusing on advanced product development strategies to sustain themselves in the sector and gain a higher revenue share. For instance, in May 2015, Medtronic announced that its Arctic Front Advance ST Cryoablation Catheter received U.S. Food and Drug Administration approval for its use in the treatment of atrial fibrillation. Innovative technologies and advanced product development endeavors help manufacturers strengthen their position in the sector.
Currently, there are several small and large vendors present in this vertical. The key players are Mectronic Medicale S.r.l., CryoConcepts LP, Brymill Cryogenic Systems, Metrum Cryoflex, Medtronic, CooperSurgical, Inc., Cryoalfa, Erbe Elektromedizin GmbH, Cortex Technology, Special Medical Technology Co., Ltd., Physiomed Elektromedizin AG, Galil Medical, Inc., Wallach Surgical Devices, Sanarus, and Zimmer MedizinSystems.